Bethlehem’s OraSure gets FDA emergency authorization for Ebola test
Bethlehem’s OraSure Technologies, a developer of point-of-care and home diagnostic testing and sample collection technologies, has received emergency use authorization from the U.S. Food and Drug Administration for its second generation OraQuick Ebola 2.0 …